vs
Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and INSEEGO CORP. (INSG). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $48.4M, roughly 1.8× INSEEGO CORP.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 1.0%, a 21.8% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 0.6%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $11.6M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 13.6%).
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
Inseego Corp designs, manufactures and delivers advanced 5G and IoT solutions including mobile hotspots, edge computing devices, and cloud-based device management platforms. It primarily serves telecom operators, enterprise clients, and public sector customers across global markets.
FDMT vs INSG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $85.1M | $48.4M |
| Net Profit | $19.4M | $469.0K |
| Gross Margin | — | 42.2% |
| Operating Margin | 17.3% | 2.7% |
| Net Margin | 22.8% | 1.0% |
| Revenue YoY | 8508900.0% | 0.6% |
| Net Profit YoY | 139.1% | 182.9% |
| EPS (diluted) | $0.43 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $85.1M | $48.4M | ||
| Q3 25 | $90.0K | $45.9M | ||
| Q2 25 | $15.0K | $40.2M | ||
| Q1 25 | $14.0K | $31.7M | ||
| Q4 24 | $1.0K | $48.1M | ||
| Q3 24 | $3.0K | $54.0M | ||
| Q2 24 | $5.0K | $51.6M | ||
| Q1 24 | $28.0K | $37.5M |
| Q4 25 | $19.4M | $469.0K | ||
| Q3 25 | $-56.9M | $1.4M | ||
| Q2 25 | $-54.7M | $507.0K | ||
| Q1 25 | $-48.0M | $-1.6M | ||
| Q4 24 | — | $-566.0K | ||
| Q3 24 | $-43.8M | $9.0M | ||
| Q2 24 | $-35.0M | $624.0K | ||
| Q1 24 | $-32.4M | $-4.5M |
| Q4 25 | — | 42.2% | ||
| Q3 25 | — | 41.6% | ||
| Q2 25 | — | 41.1% | ||
| Q1 25 | — | 47.3% | ||
| Q4 24 | — | 37.3% | ||
| Q3 24 | — | 34.8% | ||
| Q2 24 | — | 36.4% | ||
| Q1 24 | — | 35.3% |
| Q4 25 | 17.3% | 2.7% | ||
| Q3 25 | -67983.3% | 4.7% | ||
| Q2 25 | -396373.3% | 3.2% | ||
| Q1 25 | -383007.1% | -1.3% | ||
| Q4 24 | — | 3.7% | ||
| Q3 24 | -1704400.0% | 1.9% | ||
| Q2 24 | -849120.0% | 3.6% | ||
| Q1 24 | -136200.0% | -7.9% |
| Q4 25 | 22.8% | 1.0% | ||
| Q3 25 | -63195.6% | 3.1% | ||
| Q2 25 | -364386.7% | 1.3% | ||
| Q1 25 | -342657.1% | -5.0% | ||
| Q4 24 | — | -1.2% | ||
| Q3 24 | -1461433.3% | 16.6% | ||
| Q2 24 | -699060.0% | 1.2% | ||
| Q1 24 | -115717.9% | -11.9% |
| Q4 25 | $0.43 | $-0.02 | ||
| Q3 25 | $-1.01 | $0.03 | ||
| Q2 25 | $-0.98 | $-0.03 | ||
| Q1 25 | $-0.86 | $-0.16 | ||
| Q4 24 | — | $0.62 | ||
| Q3 24 | $-0.79 | $-0.06 | ||
| Q2 24 | $-0.63 | $-0.02 | ||
| Q1 24 | $-0.66 | $-0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $402.7M | $24.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $505.7M | $-4.0M |
| Total Assets | $566.7M | $93.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $402.7M | $24.9M | ||
| Q3 25 | $305.1M | $14.6M | ||
| Q2 25 | $293.2M | $13.2M | ||
| Q1 25 | $321.4M | $35.1M | ||
| Q4 24 | $424.9M | $39.6M | ||
| Q3 24 | $501.9M | $12.0M | ||
| Q2 24 | $541.9M | $49.0M | ||
| Q1 24 | $525.9M | $12.3M |
| Q4 25 | $505.7M | $-4.0M | ||
| Q3 25 | $369.0M | $-7.7M | ||
| Q2 25 | $420.9M | $-10.5M | ||
| Q1 25 | $469.7M | $-13.0M | ||
| Q4 24 | $510.6M | $-12.9M | ||
| Q3 24 | $552.9M | $-85.1M | ||
| Q2 24 | $588.3M | $-101.8M | ||
| Q1 24 | $600.6M | $-105.6M |
| Q4 25 | $566.7M | $93.8M | ||
| Q3 25 | $424.0M | $85.8M | ||
| Q2 25 | $473.6M | $83.1M | ||
| Q1 25 | $515.7M | $93.0M | ||
| Q4 24 | $560.4M | $100.0M | ||
| Q3 24 | $604.0M | $113.4M | ||
| Q2 24 | $620.1M | $149.6M | ||
| Q1 24 | $629.9M | $122.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.6M | $12.0M |
| Free Cash FlowOCF − Capex | $28.5M | $11.6M |
| FCF MarginFCF / Revenue | 33.5% | 24.0% |
| Capex IntensityCapex / Revenue | 0.1% | 0.7% |
| Cash ConversionOCF / Net Profit | 1.47× | 25.50× |
| TTM Free Cash FlowTrailing 4 quarters | $-109.9M | $6.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.6M | $12.0M | ||
| Q3 25 | $-46.5M | $3.2M | ||
| Q2 25 | $-43.4M | $-4.5M | ||
| Q1 25 | $-47.8M | $-3.5M | ||
| Q4 24 | $-134.6M | $-14.2M | ||
| Q3 24 | $-29.4M | $14.8M | ||
| Q2 24 | $-30.2M | $27.6M | ||
| Q1 24 | $-29.1M | $5.2M |
| Q4 25 | $28.5M | $11.6M | ||
| Q3 25 | $-46.6M | $3.1M | ||
| Q2 25 | $-43.4M | $-4.7M | ||
| Q1 25 | $-48.4M | $-3.5M | ||
| Q4 24 | $-138.4M | $-14.3M | ||
| Q3 24 | $-31.2M | $14.8M | ||
| Q2 24 | $-30.6M | $27.6M | ||
| Q1 24 | $-29.8M | — |
| Q4 25 | 33.5% | 24.0% | ||
| Q3 25 | -51765.6% | 6.7% | ||
| Q2 25 | -289620.0% | -11.6% | ||
| Q1 25 | -345635.7% | -11.0% | ||
| Q4 24 | -13837100.0% | -29.7% | ||
| Q3 24 | -1038966.7% | 27.4% | ||
| Q2 24 | -611840.0% | 53.5% | ||
| Q1 24 | -106421.4% | — |
| Q4 25 | 0.1% | 0.7% | ||
| Q3 25 | 101.1% | 0.2% | ||
| Q2 25 | 440.0% | 0.5% | ||
| Q1 25 | 4507.1% | 0.1% | ||
| Q4 24 | 378600.0% | 0.1% | ||
| Q3 24 | 59266.7% | 0.0% | ||
| Q2 24 | 6980.0% | 0.0% | ||
| Q1 24 | 2535.7% | 0.0% |
| Q4 25 | 1.47× | 25.50× | ||
| Q3 25 | — | 2.22× | ||
| Q2 25 | — | -8.81× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.65× | ||
| Q2 24 | — | 44.31× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
